GENE ONLINE|News &
Opinion
Blog

In-Depth
Successful Gene-Editing to Reverse Deafness Scores Another Win for Gene Therapy
2020-06-07
ASCO 2020: Immunotherapy Gives Hope to Women with Placental Cancer
2020-06-01
Colorectal Cancer: An Outlook on the Disease and Treatments
2020-05-27
Cystic Fibrosis: ZFN Mediated Gene Editing Results in Functional CFTR Correction
2020-05-13
An Outlook on the Evolution of Cystic Fibrosis Care
2020-05-13
Virus-Associated Cancers and Advancements in Their Treatments
2020-05-03
Is Antibiotic Resistance Here to Stay?
2020-04-22
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
TIGIT Immunotherapy: A Ray of Hope for Cancer Treatment?
2020-04-04
Gut Bacteria and Cancer: From Cancer Development to Precision Medicine
2020-03-29
Gearing Towards a Microbiome Driven Therapy for Fighting Inflammatory Diseases
2020-03-20
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
Peeking into the Future of Synthetic Biology and Gene Editing, an Exclusive Interview with Dr. George Church
2020-02-13
Understanding the Scientific Challenges in Combating the New Coronavirus
2020-02-11
February 4th 2020, World Cancer Day
2020-02-04
1 6 7 8 9 10
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top